Beyond ePrescribing
description
Transcript of Beyond ePrescribing
![Page 1: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/1.jpg)
Beyond ePrescribingFactors Influencing Patient Safety in Medical Group Practices - September 26th, 2007AHRQ 2007: Improving Healthcare, Improving LiveLarry Garber, M.D. – Medical Director for Informatics
![Page 2: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/2.jpg)
![Page 3: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/3.jpg)
3
Overview
• Sources of Adverse Drug Events (ADE’s) in the ambulatory setting
• Reducing anticoagulant-related ADE’s• Future plans and barriers to reducing
ADE’s
![Page 4: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/4.jpg)
SourceSource Total ADEsTotal ADEs Preventable Preventable (%)(%)
ER notesER notes 187187 37%37%
Hospital D/C’sHospital D/C’s 166166 35%35%
Computer Computer signalssignals
439439 34%34%
Electronic notesElectronic notes 565565 20%20%
Provider reportsProvider reports 168168 15%15%
Incident reportsIncident reports 55 60%60%
Sources of ADE Information
Field, TS et al. JAMIA 2004;52:1349-1354.
![Page 5: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/5.jpg)
ADE Rates in the Ambulatory Setting
• ADEs:50 per 1000 person-years
• Preventable ADEs:14 per 1000 person-years (28%)
• Extrapolated to total Medicare 65+:1,446,949 ADEs per year438,046 preventable ADEs/year
• This is likely to be an underestimate
Gurwitz JH et al JAMA 2003;289:1107-1116
![Page 6: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/6.jpg)
Financial Cost of ADE’s
0.00
500.00
1000.00
1500.00
2000.00
2500.00
12-11 10-9 8-7 6-5 4-3 2-1 1-2 3-4 5-6 7-8 9-10 11-12
Pre-Period Post-PeriodDay of the ADE
Weeks Before and After Date of ADE
Field TS, et al Medical Care 2005;43:1171-6
![Page 7: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/7.jpg)
Financial Cost of ADE’s
• Increase in costs after an ADE: $1310Increase after a preventable ADE: $1983
• Extrapolated to 1000 adults age 65+Costs per year to treat preventable ADEs:$27,365
![Page 8: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/8.jpg)
ADE Severity in the Ambulatory Setting
Fatal 0.6%
Life-threatening
11.1%
Serious 28.3%
LessSerious
60%
![Page 9: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/9.jpg)
Severity & Preventability
Preventable52%
Of fatal & life-threatening events
Preventable20%
Of less serious events
![Page 10: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/10.jpg)
Source of Errors
Other19%
Ordering39%
Monitoring42%
![Page 11: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/11.jpg)
So where do you start?
11
![Page 12: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/12.jpg)
12
![Page 13: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/13.jpg)
13
![Page 14: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/14.jpg)
14
![Page 15: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/15.jpg)
Fallon Approach to Preventing ADE’s
• First target the Fatal & Life-Threatening preventable ADE’s Warfarin
• Then do a system-wide solution for the others
15
![Page 16: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/16.jpg)
Preventing Warfarin ADE’s
• Ordering/Prescribing ePrescribing with drug interaction
checking Simplified referrals to Anticoagulation
Clinic
• Monitoring Converted Anticoagulation Clinic to Epic’s
EHR Simplified tracking of lab no-shows
16
![Page 17: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/17.jpg)
17
Full dosing information is entered and available to be seen by all physicians and staff
Date of next INR is entered to trigger tickler system
![Page 18: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/18.jpg)
18
INR Reminder automatically appears in the Anticoagulation Clinic In-basket on the patient’s due date, and doesn’t disappear until the due date is changed
INR Reminder automatically appears in the Anticoagulation Clinic In-basket on the patient’s due date, and doesn’t disappear until the due date is changed
![Page 19: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/19.jpg)
Preventing Other ADE’s
• Use probabilistic risk assessment to: characterize systemic and behavioral
elements that increase of ADE’s during ordering/monitoring
identify potentially high-yield and likely-to-be-successful interventions
• Estimate likelihood that interventions at any given step would be successful in reducing errors at that step
• Select interventions for implementation19
Field TS et al AHRQ Grant # 1P20HS017109-01
![Page 20: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/20.jpg)
Barriers to preventing ADE’s
• Most organizations don’t have EHR’s• ePrescribing doesn’t solve the
monitoring problem• Many EHR’s don’t currently have the
functionality to provide alerts for missing events without being in the context of a patient encounter
• MD compliance• Time and money required to build
interventions20
![Page 21: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/21.jpg)
Summary:
• ADEs are common and often preventable
• Types of errors suggest focus on prescribing and monitoring Provision of information to physicians and
assistants at right time, right place…Use of automated tickler systems
• Costs are high and savings from preventing ADEs could partially offset costs of interventions
![Page 22: Beyond ePrescribing](https://reader035.fdocuments.net/reader035/viewer/2022062807/5681501f550346895dbe0506/html5/thumbnails/22.jpg)
22
Questions?
Larry Garber, [email protected]
Special thanks to Terry Field, PhD and Jerry Gurwitz, M.D. for their assistance on this presentation and never-ending work to
study and prevent ADE’s